Tariao, Kim Ryan E.
HRN: 26-92-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
CEFTRIAXONE 1G (VIAL)
04/09/2025
04/16/2025
IV
2g
OD
Infected Wound Sec To Ahoulder Dislocation
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes